USF1 and dyslipidemias: Converging evidence for a functional intronic variant

Human Molecular Genetics

Volumn 14, Issue 17, 2005, Pages 2595-2605

  Naukkarinen, Jussi ^a,b   Gentile, Massimiliano ^a,b   Soro Paavonen, Aino ^c   Saarela, Janna ^a,b   Koistinen, Heikki A ^c   Pajukanta, Päivi ^d   Taskinen, Marja Riitta ^c   Peltonen, Leena ^a,b,d  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adrenergic; Beta; Heart failure; Lymphocytes; Prognosis; Receptors; Signal transduction

Indexed keywords

APOLIPOPROTEIN E; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; UPSTREAM STIMULATORY FACTOR 1;

ADULT; ALLELE; ARTICLE; BODY FAT; CLINICAL ARTICLE; DISEASE ASSOCIATION; DNA SEQUENCE; DOWN REGULATION; DYSLIPIDEMIA; FAMILIAL DISEASE; FEMALE; GENE CONTROL; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC CODE; GENETIC RISK; GENETIC VARIABILITY; GLUCOSE METABOLISM; HUMAN; HYPERLIPIDEMIA; INTRON; LIPID ANALYSIS; LIPID METABOLISM; MALE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION;

ANIMALS; BASE SEQUENCE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HYPERLIPIDEMIAS; INTRONS; MOLECULAR SEQUENCE DATA; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, NUCLEIC ACID; TRANSCRIPTION FACTORS; UPSTREAM STIMULATORY FACTORS; VARIATION (GENETICS);

EID: 24144470503     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddi294     Document Type: Article

References (37)

1. Goldstein, J.L., Schrott, H.G., Hazzard, W.R., Bierman, E.L. and Motulsky, A.G. (1973) Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J. Clin. Invest., 52, 1544-1568.
2. Nikkila, E.A. and Aro, A. (1973) Family study of serum lipids and lipoproteins in coronary heart-disease. Lancet, 1, 954-959.
3. Wojciechowski, A.P., Farrall, M., Cullen, P., Wilson, T.M., Bayliss, J.D., Farren, B., Griffin, B.A., Caslake, M.J., Packard, C.J., Shepherd, J. et al. (1991) Familial combined hyperlipidaemia linked to the apolipoprotein AI-CII-AIV gene cluster on chromosome 11q23-q24. Nature, 349, 161-164.
4. Aouizerat, B.E., Allayee, H., Cantor, R.M., Dallinga-Thie, G.M., Lanning, C.D., de Bruin, T.W., Lusis, A.J. and Rutter, J.I. (1999) Linkage of a candidate gene locus to familial combined hyperlipidemia: lecithin: Cholesterol acyltransferase on 16q. Arterioscler. Thromb. Vasc. Biol., 19, 2730-2736.
5. Pajukanta, P., Terwilliger, J.D., Perola, M., Hiekkalinna, T., Nuotio, I., Ellonen, P., Parkkonen, M., Hartiala, J., Ylitalo, K., Pihlajamaki, J. et al. (1999) Genomewide scan for familial combined hyperlipidemia genes in finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels. Am. J. Hum. Genet., 64, 1453-1463.
6. Pajukanta, P., Lilja, H.E., Sinsheimer, J.S., Cantor, R.M., Lusis, A.J., Gentile, M., Duan, X.J., Soro-Paavonen, A., Naukkarinen, J., Saarela, J. et al. (2004) Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1). Nat. Genet., 36, 371-376.
7. Putt, W., Palmen, J., Nicaud, V., Tregouet, D.A., Tahri-Daizadeh, N., Flavell, D.M., Humphries, S.E. and Talmud, P.J. (2004) Variation in USF1 shows haElotype effects, gene:gEne and gene: environment associations with glucose and lipid parameters in the European Atherosclerosis Research Study II. Hum. Mol. Genet., 13, 1587-1597.
8. Casado, M., Vallet, V.S., Kahn, A. and Vaulont, S. (1999) Essential role in vivo of upstream stimulatory factors for a normal dietary response of the fatty acid synthase gene in the liver. J. Biol. Chem. 274, 2009-2013.
9. Ribeiro, A., Pastier, D., Kardassis, D., Chambaz, J. and Cardot, P. (1999) Cooperative binding of upstream stimulatory factor and hepatic nuclear factor 4 drives the transcription of the human apolipoprotein A-II gene. J. Biol. Chem., 274, 1216-1225.
10. Groenen, P.M., Garcia, E., Debeer, P., Devriendt, K., Fryns, J.P. and Van de Ven, W.J. (1996) Structure, sequence, and chromosome 19 localization of human USF2 and its rearrangement in a patient with multicystic renal dysplasia. Genomics, 38, 141-148.
11. Hopkins, P.N., Heiss, G., Ellison, R.C., Province, M.A., Pankow, J.S., Eckfeldt, J.H. and Hunt, S.C. (2003) Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: A case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study. Circulation, 108, 519-523.
12. Horikawa, Y., Oda, N., Cox, N.J., Li, X., Orho-Melander, M., Hara, M., Hinokio, Y., Lindner, T.H., Mashima, H., Schwarz, P.E. et al. (2000) Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat. Genet., 26, 163-175.
13. Rioux, J.D., Daly, M.J., Silverberg, M.S., Lindblad, K., Steinhart, H., Cohen, Z., Delmonte, T., Kocher, K., Miller, K., Guschwan, S. et al. (2001) Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat. Genet., 29, 223-228.
14. Shoulders, C.C. (2004) USF1 on trial. Nat. Genet., 36, 322-323.
15. Lefrancois-Martinez, A.M., Martinez, A., Antoine, B., Raymondjean, M. and Kahn, A. (1995) Upstream stimulatory factor proteins are major components of the glucose response complex of the L-type pyruvate kinase gene promoter. J. Biol. Chem., 270, 2640-2643.
16. Viollet, B., Lefrancois-Martinez, A.M., Henrion, A., Kahn, A., Raymondjean, M. and Martinez, A. (1996) Immunochemical characterization and transacting properties of upstream stimulatory factor isoforms. J. Biol. Chem., 271, 1405-1415.
17. Yang, X.P., Freeman, L.A., Knapper, C.L., Amar, M.J., Remaley, A., Brewer, H.B., Jr and Santamarina-Fojo, S. (2002) The E-box motif in the proximal ABCA1 promoter mediates transcriptional repression of the ABCA1 gene. J. Lipid. Res., 43, 297-306.
18. Yanai, K., Saito, T., Hirota, K., Kobayashi, H., Murakami, K. and Fukamizu, A. (1997) Molecular variation of the human angiotensinogen core promoter element located between the TATA box and transcription initiation site affects its transcriptional activity. J. Biol. Chem. 272, 30558-30562.
19. Salero, E., Gimenez, C. and Zafra, F. (2003) Identification of a non-canonical E-box motif as a regulatory element in the proximal promoter region of the apolipoprotein E gene. Biochem. J., 370 979-986.
20. Nowak, M., Helleboid-Chapman, A., Jakel, H., Martin, G., Duran-Sandoval, D., Staels, B., Rubin, E.M., Pennacchio, L.A., Taskinen, M.R., Fruchart-Najib, J. et al. (2005) Insulin-mediated down-regulation of apolipoprotein A5 gene expression through the phosphatidylinositol 3-kinase pathway: Role of upstream stimulatory factor. Mol. Cell. Biol., 25, 1537-1548.
21. Wallace, T.M., Levy, J.C. and Matthews, D.R. (2004) Use and abuse of HOMA modeling. Diabetes Care, 27, 1487-1495.
22. Lopez-Casillas, F., Ponce-Castaneda, M.V. and Kim, K.H. (1991) In vivo regulation of the activity of the two promoters of the rat acetyl coenzyme-A carboxylase gene. Endocrinology, 129, 1049-1058.
23. Mootha, V.K., Lindgren, C.M., Eriksson, K.F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstrale, M., Laurila, E. et al. (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet., 34, 267-273.
24. Dyrskjot, L., Thykjaer, T., Kruhoffer, M., Jensen, J.L., Marcussen, N., Hamilton-Dutoit, S., Wolf, H. and Orntoft, T.F. (2003) Identifying distinct classes of bladder carcinoma using microarrays. Nat. Genet. 33, 90-96.
25. Zhao, Q., Ishibashi, M., Hiasa, K., Tan, C., Takeshita, A. and Egashira, K. (2004) Essential role of vascular endothelial growth factor in angiotensin II-induced vascular inflammation and remodeling. Hypertension, 44, 264-270.
26. Oram, J.F. (2002) ATP-binding cassette transporter A1 and cholesterol trafficking. Curr. Opin. Lipidol., 13, 373-381.
27. Brooks-Wilson, A., Marcil, M., Clee, S.M., Zhang, L.H., Roomp, K., van Dam, M., Yu, L., Brewer, C., Collins, J.A., Molhuizen, H.O. et al. (1999) Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat. Genet., 22, 336-345.
28. Zhang, S.H., Reddick, R.L., Piedrahita, J.A. and Maeda, N. (1992) Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science, 258, 468-471.
29. Beisiegel, U., Weber, W. and Bengtsson-Olivecrona, G. (1991) Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. Proc. Natl Acad. Sci. USA, 88, 8342-8346.
30. Mahley, R.W. (1988) Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science, 240, 622-630.
31. Shimano, H., Yamada, N., Katsuki, M., Shimada, M., Gotoda, T., Harada, K., Murase, T., Fukazawa, C., Takaku, F. and Yazaki, Y. (1992) Overexpression of apolipoprotein E in transgenic mice: Marked reduction in plasma lipoproteins except high density lipoprotein and resistance against diet-induced hypercholesterolemia. Proc. Natl Acad. Sci. USA 89, 1750-1754.
32. Wilhelm, M.G. and Cooper, A.D. (2003) Induction of atherosclerosis by human chylomicron remnants: A hypothesis. J. Atheroscler. Thromb., 10, 132-139.
33. Kypreos, K.E., Li, X., van Dijk, K.W., Havekes, L.M. and Zannis, V.I. (2003) Molecular mechanisms of type III hyperlipoproteinemia: The contribution of the carboxy-terminal domain of ApoE can account for the dyslipidemia that is associated with the E2/E2 phenotype. Biochemistry, 42, 9841-9853.
34. Rall, S.C., Jr and Mahley, R.W. (1992) The role of apolipoprotein E genetic variants in lipoprotein disorders. J. Intern. Med., 231 653-659.
35. Heeren, J., Grewal, T., Laatsch, A., Becker, N., Rinninger, F., Rye, K.A. and Beisiegel, U. (2004) Impaired recycling of apolipoprotein E4 is associated with intracellular cholesterol accumulation. J. Biol. Chem., 279, 55483-55492.
36. Ha, J., Daniel, S., Kong, I.S., Park, C.K., Tae, H.J. and Kim, K.H. (1994) Cloning of human acetyl-CoA carboxylase cDNA. Eur. J. Biochem. 219, 297-306.
37. Soro, A., Pajukanta, P., Lilja, H.E., Ylitalo, K., Hiekkalinna, T., Perola, M., Cantor, R.M., Viikari, J.S., Taskinen, M.R. and Peltonen, L. (2002) Genome scans provide evidence for low-HDL-C loci on chromosomes 8q23, 16q24.1-24.2, and 20q13.11 in Finnish families. Am. J. Hum. Genet., 70, 1333-1340.